Home World News Adding Blinatumomab to Chemotherapy Improves DFS in Patients with Newly Diagnosed Childhood... World News Adding Blinatumomab to Chemotherapy Improves DFS in Patients with Newly Diagnosed Childhood Standard-Risk B-Cell ALL of Average or High Risk of Relapse By Ogkologos - January 13, 2025 1020 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the COG AALL1731 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR PET Positivity After Two Cycles of ABVD Is Associated with a... November 22, 2023 Soaring skin cancer cases hit a record high July 7, 2023 Adding Retifanlimab To Chemotherapy Provides OS Benefit over Chemotherapy In First-Line... May 18, 2026 Get to Know CaringBridge June 3, 2021 Load more HOT NEWS ASCO20 Virtual Research Round Up Podcast: Central Nervous System Tumors and... Fatiga relacionada con el cáncer: Lo que las personas con cáncer... FDA Grants Accelerated Approval to Tovorafenib for Patients with Relapsed or... Safety and Preliminary Signs of Activity of OMO-103, a MYC Inhibitor,...
